Conjunctival vascularization assessed by AS-OCTA as a biomarker of ocular involvement in primary Sjögren’s syndrome

Clicks: 3
ID: 319760
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #45 of 46 articles by views in Rheumatology Advances in Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objectives To determine whether conjunctival vascularization is increased in primary Sjögren’s syndrome (pSS) and whether it reflects systemic disease activity. Methods Forty-one pSS patients and 39 matched healthy controls (HC) without ocular disease or dryness-inducing drugs underwent Schirmer test, tear break-up time (BUT), Oxford grading, Ocular Surface Disease Index (OSDI) and anterior segment OCT-angiography (AS-OCTA) of temporal conjunctiva. Conjunctival vessels were segmented on grey-scale images using a fixed threshold and expressed as vessel percentage. pSS also underwent a full rheumatologic assessment. Results pSS patients had low systemic disease activity (median ESSDAI 0), long disease duration (median 9 years) and high symptom burden (ESSPRI 8). Conjunctival vascularization was significantly increased in pSS compared with HC (0.25 vs 0.13, p < 0.001). Tear function was reduced in pSS (lower Schirmer and BUT, higher OSDI and Oxford scores; all p < 0.001). An AS-OCTA cut-off ≥0.1941 optimally discriminated pSS from HC (AUC 0.88, sensitivity 94.9%, specificity 78.1%), outperforming Schirmer (AUC 0.76, sensitivity 88.9%, specificity 51.3%). About 78% of pSS patients had AS-OCTA ≥0.1941, compared with 10.2% of HC (p < 0.001). Subjects with pathological AS-OCTA values had lower Schirmer and BUT values, and higher OSDI scores (all p ≤ 0.001). Conjunctival vascularization weakly correlated with C3 levels (r=-0.36, p = 0.03), but not with C4 or other markers of systemic inflammation. Conclusion AS-OCTA can effectively detect conjunctival vascular changes in pSS patients, offering an objective, non-invasive, and more sensitive method to assess eye dryness, reflecting the importance of a multidisciplinary management of the condition. Its potential link to systemic inflammation warrants further investigation.
Reference Key
openalex_W7167484216 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Benedetta Monosi, Sara Ferrigno, Isabella Corsi, Carlo Nucci, Maria Sole Chimenti, Francesco Aiello, Massimo Cesareo, Paola Conigliaro
Journal Rheumatology Advances in Practice
Year 2026
DOI
10.1093/rap/rkag074
URL
https://doi.org/10.1093/rap/rkag074
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.